Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)

Market Cap	14.40B
Revenue (ttm)	716.59M
Net Income (ttm)	94.30M
Shares Out	423.51M
EPS (ttm)	0.22
PE Ratio	153.44
Forward PE	56.67
Dividend	0.20 (0.59%)
Ex-Dividend Date	May 27, 2025

Volume	3,641,480
Average Volume	16,016,531
Open	34.70
Previous Close	34.95
Day's Range	34.22 - 35.20
52-Week Range	11.92 - 39.46
Beta	0.09
RSI	58.82
Earnings Date	Aug 28, 2025

About SHE:301263

Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company provides products covering various therapeutic areas, including gender health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the forms of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as an ag...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 1,081
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301263

Financial Performance

In 2024, SHE:301263's revenue was 721.03 million, a decrease of -5.23% compared to the previous year's 760.79 million. Earnings were 108.22 million, a decrease of -32.45%.